Search
for
Sort by
Research 151–180 of 200
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Recent advances in Forensic DNA Phenotyping of appearance, ancestry and age
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Radiolabel validation of cortisol in the hair of rhesus monkeys
- Common Skin Disorders in Pediatric Skin of Color
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications
- Hair Follicle Development and Cashmere Traits in Albas Goat Kids
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Epigenetic age estimation in saliva and in buccal cells
- Skin manifestations associated with COVID-19
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- A review of genotrichoses and hair pathology associated with inherited skin diseases
- Root hair growth from the pH point of view
- Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
- Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature
- Medical Dermatology
- Management of psychiatric disorders with HIV and dermatological disorders
- Herb lotions to regrow hair in patients with intractable alopecia areata
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Annual Convention in the Time of COVID
- Menopause and hair loss in women: Exploring the hormonal transition
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- COVID-19 and Autoimmunity in Dermatology: A Moroccan Case Series and Literature Review
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- ZALCITABINE
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”